Fosun Pharma and Genuine Biotech increase production of COVID drug Azvudine in collaboration with companies

BEIJING (Reuters), – Shanghai Fosun Pharmaceutical announced Friday that it and Henan Genuine Biotech would collaborate with other companies to increase production of Azvudine, a COVID treatment.

According to the company, demand has increased since the government lifted its zero COVID restrictions.

(Reporting from Beijing Newsroom; editing done by Jason Neely